CIK 0000885725
BSX BOSTON SCIENTIFIC CORP
Insider trading from SEC Form 4. Last filing Dec 4, 2024.
Last 90 days
Net insider value
$0
no open-market trades
Buys
0
$0 by 0 insiders
Sells
0
$0 by 0 insiders
Insiders on file
7
with a Form 4 at this company
Signals
Open-market buys and sells at BOSTON SCIENTIFIC CORP, scored.
| Score | Side | Insider | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 20Weak | sell 410b5-1 | Carruthers Wendy EVP, Human Resources | $634k | 6,983 | -19% | - | |
| 50Moderate | sell 4 | Woodworth Emily SVP, Global Controller and CAO | $121k | 1,336 | -31% | - | |
| 50Moderate | sell 410b5-1 | Butcher Arthur C EVP& Grp Pres, MedSurg & APAC | $1.3M | 14,010 | -93% | - | |
| 52Moderate | sell 5 | LUDWIG EDWARD J director | $447k | 4,877 | -11% | - | |
| 30Weak | sell 410b5-1 | Sorenson John Bradley EVP, Global Operations | $2.7M | 30,580 | -44% | - | |
| 30Weak | sell 310b5-1 | Mahoney Michael F Chairman, President & CEO | $14M | 162,778 | -10% | - | |
| 19Weak | sell 310b5-1 | Carruthers Wendy EVP, Human Resources | $589k | 6,983 | -18% | - |
Congressional trades
40 trades in BSX disclosed by members of Congress under the STOCK Act, the newest 20 shown. All congressional trades.
| Member | Type | Asset | Amount | Traded | Filed |
|---|---|---|---|---|---|
| Kevin Hern House · R-OK | Partial sale | BSX Boston Scientific Corporation Common Stock | $50k to $100k | Sep 4, 2026 | 21 days after the trade |
| Kevin Hern House · R-OK | Sale | BSX Boston Scientific Corporation Common Stock | $1,001 to $15k | Sep 3, 2026 | 22 days after the trade |
| Kevin Hern House · R-OK | Sale | BSX Boston Scientific Corporation Common Stock | $1,001 to $15k | Sep 3, 2026 | 22 days after the trade |
| Kevin Hern House · R-OK | Sale | BSX Boston Scientific Corporation Common Stock | $1,001 to $15k | Sep 3, 2026 | 22 days after the trade |
| Kevin Hern House · R-OK | Sale | BSX Boston Scientific Corporation Common Stock | $50k to $100k | Sep 9, 2026 | 16 days after the trade |
| Kevin Hern House · R-OK | Sale | BSX Boston Scientific Corporation Common Stock | $15k to $50k | Aug 31, 2026 | 25 days after the trade |
| Gilbert Ray Cisneros, Jr. House · D-CA | Purchase | BSX Boston Scientific Corporation Common Stock | $1,001 to $15k | Aug 18, 2026 | 23 days after the trade |
| Alan Armstrong Senate · R-OK | Purchase | BSX Boston Scientific Corporation Common Stock | $1,001 to $15k | Mar 27, 2026 | 116 days after the trade |
| John Boozman Senate · R-AR | Partial sale | BSX Boston Scientific Corporation Common Stock | $1,001 to $15k | Jun 4, 2026 | 39 days after the trade |
| Gilbert Ray Cisneros, Jr. House · D-CA | Purchase | BSX Boston Scientific Corporation Common Stock | $1,001 to $15k | Jun 5, 2026 | 27 days after the trade |
| Gilbert Ray Cisneros, Jr. House · D-CA | Partial sale | BSX Boston Scientific Corporation Common Stock | $1,001 to $15k | Jun 5, 2026 | 27 days after the trade |
| Gilbert Ray Cisneros, Jr. House · D-CA | Purchase | BSX Boston Scientific Corporation Common Stock | $1,001 to $15k | May 11, 2026 | 28 days after the trade |
| Gilbert Ray Cisneros, Jr. House · D-CA | Purchase | BSX Boston Scientific Corporation Common Stock | $1,001 to $15k | May 19, 2026 | 20 days after the trade |
| Gilbert Ray Cisneros, Jr. House · D-CA | Purchase | BSX Boston Scientific Corporation Common Stock | $1,001 to $15k | May 29, 2026 | 10 days after the trade |
| Gilbert Ray Cisneros, Jr. House · D-CA | Purchase | BSX Boston Scientific Corporation Common Stock | $1,001 to $15k | Feb 10, 2026 | 27 days after the trade |
| Gilbert Ray Cisneros, Jr. House · D-CA | Purchase | BSX Boston Scientific Corporation Common Stock | $1,001 to $15k | Jan 30, 2026 | 14 days after the trade |
| Markwayne Mullin Senate · R-OK | Purchase | BSX Boston Scientific Corporation Common Stock | $15k to $50k | Dec 29, 2025 | 18 days after the trade |
| John Boozman Senate · R-AR | Partial sale | BSX Boston Scientific Corp | $1,001 to $15k | Dec 17, 2025 | 27 days after the trade |
| Gilbert Ray Cisneros, Jr. House · D-CA | Partial sale | BSX Boston Scientific Corporation Common Stock | $1,001 to $15k | Dec 24, 2025 | 19 days after the trade |
| Gilbert Ray Cisneros, Jr. House · D-CA | Purchase | BSX Boston Scientific Corporation Common Stock | $1,001 to $15k | Nov 18, 2025 | 27 days after the trade |
Transactions
The last 30 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 2, 2024 | Carruthers Wendy EVP, Human Resources | MOption exercise Common Stock10b5-1 | +3,066 | $17.26 | $53k | 35,094 | Dec 4, 2024 |
| Dec 2, 2024 | Carruthers Wendy EVP, Human Resources | MOption exercise Common Stock10b5-1 | +1,197 | $24.55 | $29k | 36,291 | Dec 4, 2024 |
| Dec 2, 2024 | Carruthers Wendy EVP, Human Resources | SOpen-market sale Common Stock10b5-1 | -6,983 | $90.78 | $634k | 29,308 | Dec 4, 2024 |
| Dec 2, 2024 | Carruthers Wendy EVP, Human Resources | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -3,066 | $0.00 | $0 | 0 | Dec 4, 2024 |
| Dec 2, 2024 | Carruthers Wendy EVP, Human Resources | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,197 | $0.00 | $0 | 13,183 | Dec 4, 2024 |
| Nov 27, 2024 | Woodworth Emily SVP, Global Controller and CAO | SOpen-market sale Common Stock | -1,336 | $90.65 | $121k | 2,957 | Dec 2, 2024 |
| Nov 26, 2024 | Mahoney Michael F Chairman, President & CEO | GGift Common Stockindirect: By Trust | -7,800 | $0.00 | $0 | 201,478 | Nov 27, 2024 |
| Nov 25, 2024 | Fitzgerald Joseph Michael EVP & Group Pres, Cardiology | GGift Common Stock | -1,113 | $0.00 | $0 | 159,354 | Nov 26, 2024 |
| Nov 26, 2024 | Fitzgerald Joseph Michael EVP & Group Pres, Cardiology | GGift Common Stock | -11,236 | $0.00 | $0 | 148,118 | Nov 26, 2024 |
| Nov 25, 2024 | Butcher Arthur C EVP& Grp Pres, MedSurg & APAC | MOption exercise Common Stock10b5-1 | +3,177 | $22.71 | $72k | 13,979 | Nov 25, 2024 |
| Nov 25, 2024 | Butcher Arthur C EVP& Grp Pres, MedSurg & APAC | MOption exercise Common Stock10b5-1 | +1,009 | $17.26 | $17k | 14,988 | Nov 25, 2024 |
| Nov 25, 2024 | Butcher Arthur C EVP& Grp Pres, MedSurg & APAC | SOpen-market sale Common Stock10b5-1 | -14,010 | $89.27 | $1.3M | 978 | Nov 25, 2024 |
| Nov 25, 2024 | Butcher Arthur C EVP& Grp Pres, MedSurg & APAC | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,009 | $0.00 | $0 | 4,036 | Nov 25, 2024 |
| Nov 25, 2024 | Butcher Arthur C EVP& Grp Pres, MedSurg & APAC | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -3,177 | $0.00 | $0 | 12,706 | Nov 25, 2024 |
| Nov 21, 2024 | LUDWIG EDWARD J director | SOpen-market sale Common Stock | -4,877 | $91.63 | $447k | 39,398 | Nov 22, 2024 |
| Nov 12, 2024 | Sorenson John Bradley EVP, Global Operations | GGift Common Stock | -2,610 | $0.00 | $0 | 37,096 | Nov 13, 2024 |
| Nov 8, 2024 | Sorenson John Bradley EVP, Global Operations | MOption exercise Common Stock10b5-1 | +17,362 | $24.55 | $426k | 70,286 | Nov 12, 2024 |
| Nov 8, 2024 | Sorenson John Bradley EVP, Global Operations | SOpen-market sale Common Stock10b5-1 | -30,580 | $87.66 | $2.7M | 39,706 | Nov 12, 2024 |
| Nov 8, 2024 | Sorenson John Bradley EVP, Global Operations | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -17,362 | $0.00 | $0 | 0 | Nov 12, 2024 |
| Nov 5, 2024 | Mahoney Michael F Chairman, President & CEO | MOption exercise Common Stock10b5-1 | +56,211 | $17.26 | $970k | 1,628,307 | Nov 7, 2024 |
| Nov 5, 2024 | Mahoney Michael F Chairman, President & CEO | MOption exercise Common Stock10b5-1 | +55,676 | $16.31 | $908k | 1,683,983 | Nov 7, 2024 |
| Nov 5, 2024 | Mahoney Michael F Chairman, President & CEO | SOpen-market sale Common Stock10b5-1 | -2,596 | $85.17 | $221k | 1,681,387 | Nov 7, 2024 |
| Nov 5, 2024 | Mahoney Michael F Chairman, President & CEO | SOpen-market sale Common Stock10b5-1 | -160,182 | $84.74 | $14M | 1,521,205 | Nov 7, 2024 |
| Nov 5, 2024 | Mahoney Michael F Chairman, President & CEO | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -56,211 | $0.00 | $0 | 168,635 | Nov 7, 2024 |
| Nov 5, 2024 | Mahoney Michael F Chairman, President & CEO | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -55,676 | $0.00 | $0 | 0 | Nov 7, 2024 |
| Nov 1, 2024 | Carruthers Wendy EVP, Human Resources | MOption exercise Common Stock10b5-1 | +3,066 | $17.26 | $53k | 37,814 | Nov 4, 2024 |
| Nov 1, 2024 | Carruthers Wendy EVP, Human Resources | MOption exercise Common Stock10b5-1 | +1,197 | $24.55 | $29k | 39,011 | Nov 4, 2024 |
| Nov 1, 2024 | Carruthers Wendy EVP, Human Resources | SOpen-market sale Common Stock10b5-1 | -6,983 | $84.33 | $589k | 32,028 | Nov 4, 2024 |
| Nov 1, 2024 | Carruthers Wendy EVP, Human Resources | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -3,066 | $0.00 | $0 | 3,066 | Nov 4, 2024 |
| Nov 1, 2024 | Carruthers Wendy EVP, Human Resources | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -1,197 | $0.00 | $0 | 14,380 | Nov 4, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- Butcher Arthur CEVP& Grp Pres, MedSurg & APAC
- Carruthers WendyEVP, Human Resources
- Fitzgerald Joseph MichaelEVP & Group Pres, Cardiology
- LUDWIG EDWARD Jdirector
- Mahoney Michael FChairman, President & CEO
- Sorenson John BradleyEVP, Global Operations
- Woodworth EmilySVP, Global Controller and CAO
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.